17.17 USD
▼-0.29-1.66%
盘后 17.18 +0.06%
2026-09-15
市值
$1.26B
市盈率
11.04
EPS
1.57
股息率
—
52 周区间
3.94 – 19.65
成交量
1.66M
Beta
2.60
目标价
33.00
52W 低 3.9452W 高 19.65
价格走势
公司简介
Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases. The company’s lead products candidate is the Narsoplimab (OMS721/MASP-2) for the treatment of hematopoietic stem-cell transplant-associated thrombotic microangiopathy (TA-TMA); and in Phase II clinical trial to treat COVID-19 and acute respiratory distress syndrome. It also develops OMS1029 that has completed phase I clinical trials for mannan-bind...